AstraZeneca (NASDAQ: AZN) reports 1,551,033,389 total voting rights and no treasury shares
Rhea-AI Filing Summary
AstraZeneca PLC reports an updated share capital and voting rights position in line with UK disclosure rules. As at 31 July 2026, the company’s issued share capital with voting rights consists of 1,551,033,389 ordinary shares of US$0.25 each.
No shares are held in Treasury, so the total number of voting rights is also 1,551,033,389. Shareholders may use this figure as the denominator to assess whether they must notify interests or changes in interests under the Financial Conduct Authority’s Disclosure and Transparency Rules.
Positive
- None.
Negative
- None.
Key Figures
Total voting rights: 1,551,033,389
Issued ordinary shares with voting rights: 1,551,033,389
Par value per ordinary share: US$0.25
+1 more
4 metrics
Total voting rights
1,551,033,389
Total number of voting rights in AstraZeneca PLC as at 31 July 2026
Issued ordinary shares with voting rights
1,551,033,389
Issued share capital of AstraZeneca PLC with voting rights as at 31 July 2026
Par value per ordinary share
US$0.25
Nominal value of each ordinary share in the issued share capital
Treasury shares
0
Number of AstraZeneca PLC shares held in Treasury as at 31 July 2026
Key Terms
Total Voting Rights, issued share capital, Treasury, Disclosure and Transparency Rules
4 terms
Total Voting Rights regulatory
"Total Voting Rights The following notification is made in accordance"
The total voting rights number is the count of shares that carry the right to vote at a company’s shareholder meetings, reflecting how much voting power exists in the market. Investors use it to understand control and influence—like knowing how many votes are in play when measuring ownership stakes, calculating a shareholder’s voting percentage, or assessing how easy it would be for a holder to sway decisions.
Treasury financial
"No shares are held in Treasury. Therefore, the total number"
The treasury is the department or area within a government or organization responsible for managing its money, finances, and financial strategies. It handles tasks like collecting revenue, paying bills, and planning for future financial needs, much like a household manages its budget. For investors, understanding the treasury is important because it influences interest rates, government spending, and overall economic stability.
Disclosure and Transparency Rules regulatory
"by which they will determine if they are required to notify their interest"
Rules that require companies to provide accurate, timely and complete information about their finances, operations, risks and governance to regulators, investors and the public. They matter to investors because consistent, clear reporting is like a reliable scoreboard: it makes it easier to compare companies, spot problems early, reduce surprises and fraud, and form better expectations about future performance and value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
How many total voting rights does AstraZeneca (AZN) report as of 31 July 2026?
AstraZeneca (AZN) reports 1,551,033,389 total voting rights as at 31 July 2026. This equals its issued ordinary share capital with voting rights and reflects that no shares are held in Treasury under UK Disclosure and Transparency Rule 5.6.1.
Which regulatory rule governs AstraZeneca’s (AZN) total voting rights disclosure?
The disclosure is made in accordance with the Financial Conduct Authority’s Disclosure and Transparency Rule 5.6.1. This rule requires listed companies to update the market on their total voting rights to support shareholder notification calculations.